| Ident. | Authors (with country if any) | Title |
|---|
| 000060 (2020) |
M. Roustit [France] ; R. Guilhaumou [France] ; M. Molimard [France] ; M-D Drici [France] ; S. Laporte [France] ; J-L Montastruc [France] | Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence. |
| 000061 (2020) |
Isabelle Lacroix [France] ; Justine Bénévent [France] ; Christine Damase-Michel [France] | Chloroquine and hydroxychloroquine during pregnancy: What do we know? |
| 000063 (2020) |
Lucile Grange [France] ; Philippe Guilpain [France] ; Marie-Elise Truchetet [France] ; Jean-Luc Cracowski [France] | Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review. |
| 000065 (2020) |
Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France] | "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. |
| 000157 (2020) |
P. Charlier [France] ; S. Donell [Royaume-Uni] ; D. Lippi [France, Italie] ; A. Nerlich [Allemagne] ; V. Asensi [France, Espagne] ; A. Perciaccante [France, Italie] ; O. Appenzeller [France, États-Unis] ; R. Bianucci [France, Royaume-Uni, Italie] | [Hydroxy-chloroquine to treat COVID-19 - infected patients: some lessons from medical anthropology and history of medicine]. |
| 000423 (2020) |
Frédéric Carrière [France] ; Sonia Longhi [France] ; Michel Record [France] | The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway. |
| 000510 (2020) |
Sophie Alexandra Baron [France] ; Christian Devaux [France] ; Philippe Colson [France] ; Didier Raoult [France] ; Jean-Marc Rolain [France] | Teicoplanin: an alternative drug for the treatment of COVID-19? |
| 000563 (2020) |
Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. |
| 000607 (2020) |
Yvan Jamilloux [France] ; Thomas Henry [France] ; Alexandre Belot [France] ; Sébastien Viel [France] ; Maxime Fauter [France] ; Thomas El Jammal [France] ; Thierry Walzer [France] ; Bruno François [France] ; Pascal Sève [France] | Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. |
| 000685 (2020) |
Mathieu E. Rebeaud [Suisse] ; Florian Zores [France] | SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment. |
| 000745 (2020) |
Christian Funck-Brentano [France] ; Joe-Elie Salem [France] ; Lee S. Nguyen [France] ; Milou-Daniel Drici [France] ; Dan M. Roden [États-Unis] | Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes. |
| 000769 (2020) |
Marco Alifano [France] ; Pietro Alifano [Italie] ; Patricia Forgez [France] ; Antonio Iannelli [France] | Renin-angiotensin system at the heart of COVID-19 pandemic. |
| 000951 (2020) |
Markus Zeitlinger [Autriche] ; Birgit C P. Koch [Pays-Bas] ; Roger Bruggemann [Pays-Bas] ; Pieter De Cock [Belgique] ; Timothy Felton [Royaume-Uni] ; Maya Hites [Belgique] ; Jennifer Le [États-Unis] ; Sonia Luque [Espagne] ; Alasdair P. Macgowan [Royaume-Uni] ; Deborah J E. Marriott [Australie] ; Anouk E. Muller [Pays-Bas] ; Kristina Nadrah [Slovénie] ; David L. Paterson [Australie] ; Joseph F. Standing [Royaume-Uni] ; João P. Telles [Brésil] ; Michael Wölfl-Duchek [Autriche] ; Michael Thy [France] ; Jason A. Roberts [Australie, France] | Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents. |
| 000A11 (2020) |
Patrick Brest [France] ; Jonathan Benzaquen [France] ; Daniel J. Klionsky [États-Unis] ; Paul Hofman [France] ; Baharia Mograbi [France] | Open questions for harnessing autophagy-modulating drugs in the SARS-CoV-2 war: hope or hype? |
| 000A15 (2020) |
Allan Sauvat [France] ; Fabiola Ciccosanti [Italie] ; Francesca Colavita [Italie] ; Martina Di Rienzo [Italie] ; Concetta Castilletti [Italie] ; Maria Rosaria Capobianchi [Italie] ; Oliver Kepp [France] ; Laurence Zitvogel [France, République populaire de Chine] ; Gian Maria Fimia [Italie] ; Mauro Piacentini [Italie] ; Guido Kroemer [France, République populaire de Chine, Suède] | On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. |
| 000A31 (2020) |
Franck Touret [France] ; Xavier De Lamballerie [France] | Of chloroquine and COVID-19. |
| 000A60 (2020) |
Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France] | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| 000C67 (2020) |
Biswaranjan Paital [Inde] ; Kabita Das [Inde] ; Sarat Kumar Parida [Inde] | Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India. |
| 000D01 (2020) |
Andrés Pizzorno [France] ; Blandine Padey [France] ; Julia Dubois [France] ; Thomas Julien [France] ; Aurélien Traversier [France] ; Victoria Dulière [France] ; Pauline Brun [France] ; Bruno Lina [France] ; Manuel Rosa-Calatrava [France] ; Olivier Terrier [France] | In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. |
| 000D95 (2020) |
Li Zou [République populaire de Chine] ; Lijun Dai [République populaire de Chine] ; Xingyu Zhang [République populaire de Chine] ; Zhaohui Zhang [République populaire de Chine] ; Zhentao Zhang [République populaire de Chine] | Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19. |
| 000E89 (2020) |
Christian Bailly [France] ; Gérard Vergoten [France] | Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? |
